Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-003338
Filing Date
2019-02-28
Accepted
2019-02-28 16:58:02
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3945
  Complete submission text file 0001213900-19-003338.txt   5466
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 13, HIBAT ZION, RAANANA RAANANA L3 4338111
Business Address
Hasleton Mark Daniel (Reporting) CIK: 0001759581 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 19644435